phase readout
saveNCT07223138: A Study to Evaluate the Long-term Safety, Tolerability, and Efficacy of Subcutaneous Sonelokimab in Participants With Psoriatic Arthritis
ENROLLING_BY_INVITATIONupdated 11h ago
community read0 votes
Sponsor: MoonLake Immunotherapeutics AG. Phase: PHASE3. Conditions: Arthritis, Psoriatic
view source ↗
comments(0)
5-min edit window · permanent after that